Flowflex™ SARS-CoV-2 Antigen Rapid Test
Product Features
Provides an aid in identifying individuals suspected of an active COVID-19 infection by their healthcare provider within the first seven (7) days of the onset of symptoms
Performance
- Relative Sensitivity: 97.1% (83.8%-99.9%)*
- Relative Specificity: 99.6% (97.7%-99.9%)*
- Accuracy: 99.3% (97.5%-99.9%)*
*95% Confidence Intervals












